A landmark paper published in Lancet Psychiatry—the largest-ever review of the safety and efficacy of cannabinoids across a ...
A landmark Lancet Psychiatry paper published today – the largest-ever review of the safety and efficacy of cannabinoids across a range of mental health conditions – found no evidence that medicinal ...
(Competitive Insight/Unsplash) While GLP-1 drugs such as Wegovy and Ozempic are now being broadly championed and widely used, ...
Additionally, some patients report distressing withdrawal symptoms when they try to stop, such as insomnia, anxiety, and ...
Increasing numbers of Australians are using medicinal cannabis for anxiety, depression, insomnia, substance disorders and ...
Recent research has opened the debate on whether chemical imbalances cause depression, anxiety, and other conditions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results